Corrigendum to: The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.

No author listed

No abstract available

ErratumFor

Neuro Oncol. 2024 Dec 25:noae259. doi: 10.1093/neuonc/noae259.

Article info

Journal issue:

Doi:

10.1093/neuonc/noaf032

More resources:

Silverchair Information Systems

Full Text Sources